Tomaralimab (Anti-TLR2 / CD282)

Tomaralimab (Anti-TLR2 / CD282) is a humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2) with potential anti-inflammatory and antineoplastic activities. It has the potential for research on Myelodysplastic Syndromes (MDS). MW : 145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2333
• Sku #: A2333-1mg*5